How long do benzodiazepines stay in your system? About a day to more than a month, because the class covers drugs with very different half-lives. Triazolam can be gone from urine within a day, while diazepam taken daily for months can show up for over 30 days after the last dose [1]. Between those extremes sit Xanax, Ativan, Klonopin, and Valium, the commonly prescribed prescription medications people actually ask about, all scheduled under the Controlled Substances Act.
The question usually comes up before a drug test or when someone is deciding whether it is safe to stop, which is where benzodiazepine dependence treatment in Minnesota enters the picture. This chapter explains how half-life sets the clock, gives detection times by drug and by test, and lists the factors that stretch or shrink them.
Benzodiazepine Half-Life Is the Clock
Every benzodiazepine slows the central nervous system by amplifying gamma-aminobutyric acid, the brain’s main calming signal, which is why the class is used for treating anxiety, panic disorders, muscle spasms, seizures, and alcohol withdrawal. What differs from one drug to the next is the drug’s half-life, the time the body needs to clear half of a dose, and potency, which is a separate question covered in how the strongest benzodiazepines compare.
Pharmacologists use a rule of thumb that five to seven half-lives clear about 98 percent of a drug. That gives a first estimate of how long benzodiazepines stay in the body, but only for the parent drug. Several long-acting benzodiazepines break down into active metabolites with half-lives of their own. Diazepam becomes desmethyldiazepam, temazepam, and oxazepam, and those metabolites, not diazepam itself, keep it detectable for weeks [2]. Lorazepam, oxazepam, and temazepam are handled differently: the liver attaches a sugar molecule, and the kidneys excrete the result, with no active metabolites to linger [2]. How benzos affect the brain is covered in the guide to what benzodiazepines are and how they work.
Benzodiazepine Detection Times by Drug
The groups below use approximate half-life ranges from published references [3]. The elimination estimates show roughly how long the parent drug may take to fall to low concentrations after a therapeutic dose, while the urine detection windows come from testing data. Those are different measures: repeated use can lengthen detection, particularly with long-acting benzodiazepines and active metabolites, and actual results vary with dose, metabolism, and laboratory cutoff.
Short Acting Benzodiazepines
Short-acting benzos have half-lives under about 20 hours. Triazolam (Halcion) is the extreme at roughly two hours and may be detectable in urine for only a day [1]. Alprazolam (Xanax) at 12 to 15 hours and lorazepam (Ativan) at 10 to 20 hours [3] clear the parent drug in roughly two to four days after the last dose, and published urine detection windows for Xanax run about one to four days. Lorazepam’s timeline from onset to clearance has its own chapter on lorazepam duration.
Intermediate Acting Benzodiazepines
Intermediate-acting benzodiazepines sit between the groups. Clonazepam (Klonopin) has a half-life of 20 to 60 hours [3], so the parent drug takes roughly four to twelve days to clear, and confirmatory tests look for its main metabolite, 7-aminoclonazepam, rather than the drug itself [1].
Long-Acting Benzodiazepines
Long-acting benzodiazepines have the longest detection window. Diazepam (Valium) and chlordiazepoxide (Librium) run 36 to 200 hours once their metabolites are counted [3], a week to several weeks to clear, and chronic users can remain positive for more than 30 days [1]. Which drugs last longest, and what that means for dependence, is the subject of the longest-lasting benzodiazepine chapter.
Detection Windows by Test Type
The same drug shows up for different lengths of time under different testing methods. Urine is the most commonly used sample, and drug tests can find signs of drugs taken hours to several days or more before the test, depending on the drug, the amount, how long it was used, and the person’s metabolism [5].
- Urine tests are the standard for workplace, court, and clinical drug screening. Short-acting drugs are typically detectable for a few days, long-acting drugs for a week or more, and chronic use of a long-acting drug for over 30 days [1]. Urine samples also produce the most false results, covered below.
- Blood tests generally have a shorter detection window than urine tests because they measure drug or metabolites still circulating in the bloodstream. For some short-acting benzodiazepines, blood detection may be limited to roughly 6 to 24 hours, while long-acting drugs and metabolites such as diazepam and nordiazepam can remain detectable for several days. Blood testing is used more often in clinical, toxicology or forensic situations where recent exposure or current drug concentrations matter, including cases involving what a Xanax overdose looks like
- Saliva tests detect use closer to the time it happened [4], generally within the first day or two and longer for long-acting drugs after chronic use. They are less sensitive to benzodiazepines than urine tests.
- Hair follicle testing has the longest detection window of any method, up to about 90 days [4]. Hair testing shows a pattern of use over months, not whether someone used this week.
Many routine drug-testing panels do not include benzodiazepines. Benzodiazepines are not part of the standard federal workplace drug-testing categories, which currently include amphetamines, cocaine, marijuana, opioids, and PCP, with multiple individual analytes tested within those categories. Employers or other organizations that want to test for benzodiazepines can order a panel that specifically includes them; the exact panel varies by laboratory and testing program. Xanax does not appear as an opioid result because alprazolam is a benzodiazepine, not an opioid; this point of confusion the chapter is Xanax an opioid clears up.
Which Factors Affect How Long Benzos Stay in Your System
Several factors move a person’s timeline off the averages, and most of these individual factors extend detection.
- Dose and duration. Higher doses and chronic use are the biggest variables. Long-acting drugs accumulate with daily use, so months of daily diazepam leave a far larger store than a single dose, and the drug remains detectable much longer.
- The exact drug. Half-life and metabolites, as above; within the class, detection times vary significantly.
- Age. Elderly patients clear benzodiazepines more slowly [2].
- Liver function. Most benzodiazepines are processed by liver enzymes, and certain medications that block those enzymes, including some antifungals and antibiotics, slow clearance, as does liver disease [2]. Lorazepam, oxazepam, and temazepam are less affected because they bypass that system [2].
- Kidney function. Benzodiazepines and many of their metabolites are ultimately excreted through the kidneys, so renal impairment can lengthen the persistence of some drugs or metabolites [2]. The effect varies by benzodiazepine because metabolism and renal excretion differ across the class.
- Body composition. Benzodiazepines dissolve in fat, so people with higher body fat percentages can store more of the drug and release it more slowly.
- Other drugs. Alcohol and other depressants do not change detection much, but they compound the danger while the drug is on board.
Nothing safely speeds this up. Hydration, exercise, and products sold to flush a person’s system do not change a drug’s half-life. Stopping a prescribed benzodiazepine abruptly to pass an upcoming drug test can trigger withdrawal symptoms and serious complications, for the reasons laid out in why benzodiazepine withdrawal can become a medical emergency.
Why You Can Test Positive, or Negative, When You Should Not
A positive screening result does not always prove recent benzodiazepine use, and a negative screen does not always mean the drug or its metabolites are absent. Many traditional urine benzodiazepine immunoassays were designed around metabolites such as oxazepam and nordiazepam, so sensitivity varies across the class. Lorazepam is excreted largely as a glucuronide conjugate that older assays may detect poorly, while clonazepam’s main metabolite, 7-aminoclonazepam, also has poor cross-reactivity in many screening tests. Alprazolam can be missed by some assays as well [1].
Newer assays and laboratories that use glucuronidase treatment can improve detection. False positives are also possible: sertraline, efavirenz, oxaprozin, and other medications have been reported to cross-react with some benzodiazepine immunoassays, but the risk depends on the specific assay rather than occurring at one predictable percentage [1].
Anyone with a legitimate prescription should provide an accurate medication history when results are interpreted. When a screening result is unexpected or has important clinical, employment, or legal consequences, definitive testing such as GC-MS or LC-MS/MS can identify specific benzodiazepines or metabolites and help distinguish true exposure from assay cross-reactivity. The medications that can trigger false positives are listed in our post on false positive benzodiazepine tests.
Frequently Asked Questions About Benzodiazepine Detection
How Long Do Benzos Stay in Urine?
A single therapeutic dose of a short-acting drug such as Xanax or Ativan is usually detectable in urine for a few days. Long-acting drugs such as Valium can be detected for a week or more after a single course and for over 30 days in chronic users [1].
How Long Does It Take for Benzodiazepines to Wear Off?
Effects fade well before the drug is gone. A short-acting benzodiazepine’s calming effect lasts several hours; a long-acting one, most of a day or longer. Detection outlasts the felt effect by days because tests pick up metabolites at tiny concentrations.
Why Am I Still Testing Positive for Benzodiazepines?
Usually because the drug was long-acting, the use was chronic, or clearance is slowed by age, liver or kidney function, or an interacting medication. If none of those apply, ask for confirmation testing: some antidepressants and other prescription drugs cross-react with the screen and produce false positives [1].
When the Real Question Is Dependence
Often the real question behind this one is whether benzodiazepine use has become dependence and whether it is safe to stop. The answer is not to stop suddenly: physical dependence can develop within weeks even at prescribed doses, and abrupt discontinuation can cause life-threatening seizures [7]. Northwoods Haven’s intensive outpatient program provides benzodiazepine addiction treatment under medical supervision, coordinating tapers with prescribers and addiction medicine providers, and treats the anxiety and mental health conditions underneath through individual and group therapy, on a schedule built around work and family. Reach out for a confidential conversation.
Sources
- Moeller KE, Kissack JC, Atayee RS, Lee KC, “Clinical Interpretation of Urine Drug Tests: What Clinicians Need to Know About Urine Drug Screens,” Mayo Clinic Proceedings, 2017;92(5):774-796. https://www.mayoclinicproceedings.org/article/S0025-6196(16)30825-4/fulltext
- Bounds CG, Patel P, “Benzodiazepines,” StatPearls, National Library of Medicine, last updated January 30, 2024. https://www.ncbi.nlm.nih.gov/books/NBK470159/
- Mind, “Comparing benzodiazepines,” Sleeping pills and minor tranquillisers, published April 2021. https://www.mind.org.uk/information-support/drugs-and-treatments/sleeping-pills-and-minor-tranquillisers/comparing-benzodiazepines/
- Quest Diagnostics, “Hair Drug Testing” and “Oral Fluid Drug Testing,” employer drug screening resources. https://www.questdiagnostics.com/business-solutions/employers/drug-screening/products-services/hair-testing (accessed September 23, 2026).
- MedlinePlus, “Drug Testing,” National Library of Medicine, last updated November 14, 2025. https://medlineplus.gov/lab-tests/drug-testing/
- Substance Abuse and Mental Health Services Administration, “Clinical Drug Testing in Primary Care,” Technical Assistance Publication (TAP) 32, HHS Publication No. (SMA) 12-4668, 2012. https://library.samhsa.gov/sites/default/files/sma12-4668.pdf
- U.S. Food and Drug Administration, “FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class,” Drug Safety Communication, September 23, 2020. https://www.fda.gov/drugs/drug-safety-and-availability/fda-requiring-boxed-warning-updated-improve-safe-use-benzodiazepine-drug-class
